Fluminorex
|  | |
| Clinical data | |
|---|---|
| ATC code | none | 
| Identifiers | |
| 
 | |
| CAS Number | 720-76-3  Y | 
| PubChem (CID) | 24100 | 
| ChemSpider | 22530  Y | 
| UNII | LUO2Z7954T  Y | 
| KEGG | D04210  Y | 
| ChEMBL | CHEMBL2107247 | 
| Chemical and physical data | |
| Formula | C10H9F3N2O | 
| Molar mass | 230.19 g/mol | 
| 3D model (Jmol) | Interactive image | 
| Chirality | Racemic mixture | 
| 
 | |
| 
 | |
| (verify) | |
Fluminorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also
References
- ↑ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.